Intracellular phosphatidylinositol pathway abnormalities in bipolar disorder patients

Psychopharmacology Bulletin

Volumn 33, Issue 4, 1997, Pages 685-691

  Soares, Jair C ^a,c   Mallinger, Alan G ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Pathophysiology; Phosphoinositides; Second messengers; Signal transduction

Indexed keywords

CALCIUM ION; INOSITOL; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL; PROTEIN KINASE C;

CONFERENCE PAPER; HUMAN; HYPOTHESIS; MANIC DEPRESSIVE PSYCHOSIS; NEUROCHEMISTRY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BIPOLAR DISORDER; BLOOD PLATELETS; BRAIN; CALCIUM; CELL MEMBRANE; HUMANS; PHOSPHATIDYLINOSITOLS; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 0031405823     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (78)

1. Agam, G, and Livne, A. Inositol-1-phosphatase of human erythrocytes is inhibited by therapeutic lithium concentrations. Psychiatry Res. 27:217-224, 1989.
2. Atack, JR. Inositol monophosphatase inhibitors: A novel treatment for bipolar disorder? Biol. Psychiatry 37:761-763, 1995.
3. Atack, JR. Are platelet and magnetic resonance spectroscopic changes indicative of altered PI signalling in bipolar disorder? Biol. Psychiatry 39:462-466, 1996.
4. Atack, JR; Broughton, HB; and Pollack, SJ. Inositol monophosphatase - A putative target for Li+ in the treatment of bipolar disorder. Trends in Neurosciences (TIPS) 18:343-349, 1995.
5. Banks, RE; Aiton, JF; Cramb, G; and Naylor, GJ. Incorporation of inositol into the phosphoinositides of lymphoblastoid cell lines established from bipolar manic-depressive patients. J. Affect. Disord. 19:1-8, 1990.
6. Baraban, JM; Worley, PF; and Snyder, SH. Second messenger systems and psychoactive drug action: Focus on the phosphoinositide system and lithium. Am. J. Psychiatry 146:1251-1260, 1989.
7. Belmaker, RH; Bersudsky, Y; Agam, G; Levine, J; and Kofman, O. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu. Rev. Med. 47:47-56, 1996.
8. Belmaker, RH; Bersudsky, Y; Benjamin, J; Agam, G; Levine, J; and Kofman, O. Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry. Adv. Biochem. Psychopharmacol. 49:67-84, 1995.
9. Berk, M; Bodemer, W; van Oudenhove, T; and Butkow, N. Dopamine increases platelet intracellular calcium in bipolar affective disorder and controls. Int. Clin. Psychopharmacol 9:291-293, 1994.
10. Berrettini, WH; Ferraro, TN; Goldin, LR; Weeks, DE; DeteraWadleigh, S; Nurnberger, JI Jr; and Gershon, ES. Chromosome 18 DNA markers and manic-depressive illness: Evidence for a susceptibility gene. Proc. Natl. Acad. Sci. USA 91:5918-5921, 1994.
11. Berridge, MJ; Downes, CP; and Hanley, MR. Neural and developmental actions of lithium: A unifying hypothesis. Cell 59:411-419, 1989.
12. Bowden, CL; Huang, LG; Javors, MA; Johnson, JM; Seleshi, E; McIntyre, K; Contreras, S; and Maas, JW. Calcium function in affective disorders and healthy controls. Biol. Psychiatry 23:367-376, 1988.
13. Bradshaw, D; Hill, CH; Nixon, JS; and Wilkinson, SE. Therapeutic potential of protein kinase C inhibitors. Agents Actions 38:135-147, 1993.
14. Brown, AS; Mallinger, AG; and Renbaum, LC. Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania. Am. J. Psychiatry 150:1252-1254, 1993.
15. Deicken, RF; Fein, G; and Weiner, MW. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am. J. Psychiatry 152:915-918, 1995a.
16. Deicken, RF; Weiner, MW; and Fein, G. Decreased temporal lobe phosphomonoesters in bipolar disorder. J. Affect. Disord. 33:195-199, 1995b.
17. DePetrillo, PB; Abernethy, DR; Wainer, IW; and Andrawis, NS. Verapamil decreased lymphocyte protein kinase C activity in humans. Clin. Pharmacol. Ther. 55:44-49, 1994.
18. Drummond, AH. Lithium affects G-protein receptor coupling. Nature 331:388, 1988.
19. Dubovsky, SL; Christiano, J; Daniell, LC; Franks, RD; Murphy, J; Adler, L; Baker, N; and Harris, RA. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch. Gen. Psychiatry 46:632-638, 1989.
20. Dubovsky, SL; Lee, C; Christiano, J; and Murphy, J. Elevated platelet intracellular calcium concentration in bipolar depression. Biol. Psychiatry 29:441-450, 1991.
21. Dubovsky, SL; Murphy, J; Christiano, J; and Lee, C. The calcium second messenger system in bipolar disorders: Data supporting new research directions. J. Neuropsychiatry Clin. Neurosci. 4:3-14, 1992a.
22. Dubovsky, SL; Murphy, J; Thomas, M; and Rademacher, J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am. J. Psychiatry 149:118-120, 1992b.
23. Dubovsky, SL; Thomas, M; Hijazi, A; and Murphy, J. Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. Eur. Arch. Psychiatry Clin. Neurosci. 243:229-234, 1994.
24. Ebstein, RP; Lerer, B; Bennett, ER; Dayek, DB; Newman, ME; Shapira, B; Kindler, S. Second messenger function in lymphocytes and platelets: A comparison of peripheral and central mechanisms. Clin. Neuropharmacol. 9:350-352, 1986.
25. Eckert, A; Gann, H; Riemann, D; Aldenhoff, J; and Muller, WE. Elevated intracellular calcium levels after 5HT2 receptor stimulation in platelets of depressed patients. Biol. Psychiatry 34:565-568, 1993.
26. Eckert, A; Gann, H; Riemann, D; Aldenhoff, J; and Muller, WE. Platelet and lymphocyte free intracellular calcium in affective disorders. Eur. Arch. Psychiatry Clin. Neurosci. 243:235-239, 1994.
27. el-Mallakh, RS; Harrison, LT; Li, R; Changaris, DG; and Levy, RS. An animal model for mania: Preliminary results. Prog. NeuroPsychopharmacol. Biol. Psychiatry 19:955-962, 1995.
28. 2+ response in neutrophils from patients under chronic lithium therapy. Eur. Arch. Psychiatry Clin. Neurosci. 243:240-243, 1994.
29. Friedman, E; Hoau-Yan-Wang; Levinson, D; Connell, TA; and Singh, H. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol. Psychiatry 33:520-525, 1993.
30. Friedman, E; Markowitz, PI; Undie, AS; Connell, T; and Wang, HY. "Increased protein kinase C (PKC) activation in bipolar mania." Presented at the Annual Meeting of the New Clinical Drug Evaluation Unit (NCDEU). Orlando, FL, May-June 1995.
31. Gejman, PV; Martinez, M; Cao, QH; Friedman, E; Berrettini, WH; Goldin, LR; Koroulakis, P; Ames, C; Lerman, MA; and Gershon, ES. Linkage analysis of 57 microsatellite loci to bipolar disorder. Neuropsychopharmacol. 9:31-40, 1993.
32. Hokin, LE, and Dixon, JF. The phosphoinositide signalling system. I. Historical background. II. Effects of lithium on the accumulation of second messenger inositol 1,4,5-trisphosphate in brain cortex slices. [Review]. Prog. Brain Res. 98:309-315, 1993.
33. Hudson, CJ; Young, LT; Li, PP; and Warsh, JJ. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13:278-293, 1993.
34. Imahori, Y; Fujii, R; Ueda, S; Matsumoto, K; Wakita, K; Ido, T; Nariai, T; Nakahashi, H. Membrane trapping of carbon-11-labeled 1,2-diacylglycerols as a basic concept for assessing phosphatidyl-inositol turnover in neurotransmission process. J. Nucl. Med. 33:413-422, 1992.
35. Jope, RS; Song, L; Li, PP; Young, LT; Kish, SJ; Pacheco, MA; and Warsh, JJ. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J. Neurochem. 66:2402-2409, 1996.
36. Kato, T; Shioiri, T; Murashita, J; Hamakawa, H; Inubushi, T; and Takahashi, S. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res. 55:41-50, 1994a.
37. Kato, T; Shioiri, T; Murashita, J; Hamakawa, H; Takahashi, Y; Inubushi, T; and Takahashi, S. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol. Med. 25:557-566, 1995.
38. Kato, T; Shioiri, T; Takahashi, S; and Inubushi, T. Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS. J. Affect. Disord. 22:185-190, 1991.
39. Kato, T; Takahashi, S; Shioiri, T; and Inubushi, T. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J. Affect. Disord. 26:223-230, 1992.
40. Kato, T; Takahashi, S; Shioiri, T; and Inubushi, T. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J. Affect. Disord. 27:53-59, 1993.
41. Kato, T; Takahashi, S; Shioiri, T; Murashita, J; Hamakawa, H; and Inubushi, T. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J. Affect. Disord. 31:125-133, 1994b.
42. Kusumi, I; Koyama, T; and Yamashita, I. Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients. Biol. Psychiatry 30:311-312, 1991.
43. Kusumi, I; Koyama, T; and Yamashita, I. Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders. Biol. Psychiatry 32:731-734, 1992.
44. Lachman, HM, and Papolos, DF. Abnormal signal transduction: A hypothetical model for bipolar affective disorder. Life Sci. 45:1413-1426, 1989.
45. Lachman, HM, and Papolos, DF. A molecular model for bipolar affective disorder. Med. Hypoth. 45:255-264, 1995.
46. Le, F; Mitchell, P; Vivero, C; Waters, B; Donald, J; Selbie, LA; Shine, J; and Schofield, P. Exclusion of close linkage of bipolar disorder to the Gs-alpha subunit gene in nine Australian pedigrees. J. Affect. Disord. 32:187-195, 1994.
47. Lenox, RH, and Watson, DG. Lithium and the brain: A psychopharmacological strategy to a molecular basis for manic depressive illness. [Review]. Clin. Chem. 40:309-314, 1994.
48. Levine, J; Barak, Y; Gonzalves, M; Szor, H; Elizur, A; Kofman, O; and Belmaker, RH. Double-blind, controlled trial of inositol treatment of depression. Am. J. Psychiatry 152:792-794, 1995.
49. Mallinger, AG; Yao, JK; Brown, AS; and Dippold, CS. Analysis of complex mixtures of phospholipid classes from cell membranes using two-dimensional thin-layer chromatography and scanning laser densitometry. J. Chromatogr. 614:67-75, 1993.
50. Manji, HK; Etcheberrigaray, R; Chen, G; and Olds, JL. Lithium decreases membrane-associated protein kinase C in hippocampus: Selectivity for the alpha isozyme. J. Neurochem. 61:2303-2310, 1993.
51. Manji, HK, and Lenox, RH. Long-term action of lithium: A role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 16:11-28, 1994.
52. Manji, HK; Potter, WZ; and Lenox, RH. Signal transduction pathways. Molecular targets for lithium's actions. [Review]. Arch. Gen. Psychiatry 52:531-543, 1995.
53. Molchan, SE; Atack, JR; and Sunderland, T. Decreased CS inositol monophosphatase activity after lithium treatment. Psychiatry Res. 53:103-105, 1994.
54. Molchan, SE; Manji, H; Chen, G; Dou, L; Little, J; Potter, WZ; and Sunderland, T. Effects of chronic lithium treatment on platelet PKC isozymes in Alzheimer's and elderly control subjects. Neurosci. Lett. 162:187-191, 1993.
55. Mori, H; Koyama, T; and Yamashita, I. Platelet alpha-2 adrenergic receptor-mediated phosphoinositide responses in endogenous depression. Life Sci. 48:741-748, 1991.
56. Mork, A; Geisler, A; and Hollund, P. Effects of lithium on second messenger systems in the brain. [Review]. Pharmacol. Toxicol. 71(Suppl. 1):4-17, 1992.
57. Moscovich, DG; Belmaker, RH; Agam, G; and Livne, A. Inositol-1-phosphatase in red blood cells of manic-depressive patients before and during treatment with lithium. Biol. Psychiatry 27:552-555, 1990.
58. Ohmori, Y; Imahori, Y; Ueda, S; Fujii, R; Ido, T; Wakita, K; and Nakahashi, H. Protein kinase C imaging using carbon-11-labeled phorbol 13-isobutyrate-20-[1-11C]butyrate as the potential ligand for positron emission tomography. J. Nucl. Med. 34:431-439, 1993.
59. Okamoto, Y; Kagaya, A; Shinno, H; Motohashi, N; and Yamawaki, S. Serotonin-induced platelet calcium mobilization is enhanced in mania. Life Sci. 56:327-332, 1995.
60. Palmer, AM; Lowe, SL; Francis, PT; and Bowen, DM. Are postmortem biochemical studies of human brain worthwhile? Biochem. Soc. Transact. 16:472-475, 1988.
61. Pletscher, A. Blood platelets as neuronal models: Use and limitations. Clin. Neuropharmacol. 9:344-346, 1986.
62. Ram, A; Guedj, F; Cravchik, A; Weinstein, L; Cao, Q; Badner, JA; Goldin, LR; Grisaru, N; Manji, HK; Belmaker, RH; Gershon, ES; and Gejman, PA. No abnormality in the gene for the G protein stimulatory alpha subunit in patients with bipolar disorder. Arch. Gen. Psychiatry 54:44-48, 1997.
63. Robinson, PJ; Noronha, J; DeGeorge, JJ; Freed, LM; Nariai, T; and Rapoport, SI. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: Review and critical analysis. Brain Res. Rev. 17:187-214, 1992.
64. Rotman, A. Blood platelets in psychopharmacological research. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 7:135-151, 1983.
65. Schreiber, G, and Avissar, S. Lithium sensitive G protein hyperfunction: A dynamic model for the pathogenesis of bipolar affective disorder. Med. Hypoth. 35:237-243, 1991.
66. Sharma, R; Venkatasubramanian, PN; Barany, M; and Davis, JM. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr. Res. 8:43-49, 1992.
67. Shimon, H; Agam, G; Belmaker, RH; Hyde, T; and Kleinman, JE. "Reduced inositol levels in frontal cortex of post-mortem brain from bipolar patients and suicides." Presented at the Annual Meeting of the American College of Neuropsychopharmacology (ACNP). San Juan, PR, December 1995.
68. Silverstone, PH; Hanstock, CC; Fabian, J; Staab, R; and Allen, PS. Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biol. Psychiatry 40:235-246, 1996.
69. Snyder, SH. Second messengers and affective illness - Focus on the phosphoinositide cycle. Pharmacopsychiatry 25:25-28, 1992.
70. Soares, JC; Dippold, CS; and Mallinger, AG. Platelet membrane phosphatidylinositol-4,5-bisphosphate alterations in bipolar disorder - Evidence from a single case study. Psychiatry Res. 69:197-202, 1997a.
71. Soares, JC; Dippold, CS; Mallinger, AG; Frank, E; and Kupfer, DJ. Platelet membrane phospholipids in euthymic bipolar disorder patients: Are they affected by lithium treatment? Biol. Psychiatry, in press, 1997b.
72. Soares, JC; Krishnan, KRR; and Keshavan, MS. Nuclear magnetic resonance spectroscopy - New insights into the pathophysiology of mood disorders. Depression 4:14-30, 1996.
73. Soares, JC, and Mallinger, AG. Abnormal phosphatidylinositol (PI)-signalling in bipolar disorder. Biol. Psychiatry 39:461-462, 1996.
74. Stahl, SM. Peripheral models for the study of neurotransmitter receptors in man. Psychopharmacol. Bull. 21:663-671, 1985.
75. Vadnal, R, and Parthasarathy, R. Myo-inositol monophosphatase: Diverse effects of lithium, carbamazepine, and valproate. Neuropsychopharmacol. 12:277-285, 1995.
76. van Calker, D; Forstner, U; Bohus, M; Gebicke-Harter, P; Hecht, H; Wark, HJ; and Berger, M. Increased sensitivity to agonist stimulation of the Ca2+ response in neutrophils of manic-depressive patients: Effect of lithium therapy. Neuropsychobiol. 27:180-183, 1993.
77. Wachtel, H. Dysbalance of neuronal second messenger function in the aetiology of affective disorders: A pathophysiological concept hypothesizing defects beyond first messenger receptors. J. Neural Transm. 75:21-29, 1989.
78. Wachtel, H. The second-messenger dysbalance hypothesis of affective disorders. Pharmacopsychiatry 23:27-32, 1990.